The relationship between ABO blood group and prognosis of patients with hepatocellular carcinoma (HCC) remains unclear. We investigated the relationship between prognosis and ABO blood group in patients with hepatitis B-associated HCC after radical hepatectomy. The medical records of 874 patients with hepatitis B-associated HCC who underwent radical liver tumor resection were retrospectively collected. Cox proportional risk models were constructed for analysis, and the patient data were further balanced using propensity score matching (PSM) analysis to assess the impact of ABO blood group on the prognosis of patients with hepatitis B-associated HCC. In univariate Cox regression analysis, the overall survival (OS) of non-A blood type group vs. A blood type group [hazard ratio (HR) (95% confidence interval [CI])?=?1.504 (1.003–2.255), P?=?0.048], in multivariate Cox regression analysis the OS of non-A blood type group versus A blood type group [HR (95% CI)?=?1.596 (1.054–2.417), P?=?0.027]. After PSM, the baseline information was more balanced between the two groups, yielding the same results as above [HR (95% CI)?=?1.550 (1.012–2.373), P?=?0.044]. The difference in OS after radical hepatectomy in patients with hepatitis B-associated HCC was statistically significant in terms of ABO blood group, OS was lower in patients with non-A blood group than in patients with A blood group.
展开▼
